| Lv, Weiguo |
NCT03703271: Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia |
|
|
| Recruiting | 3 | 214 | RoW | Methotrexate, Methotrexate chemotherapy, hysteroscopic repeat curettage, complete curettage | Women's Hospital School Of Medicine Zhejiang University, Sun Yat-sen University, Huazhong University of Science and Technology, Qilu Hospital of Shandong University | Gestational Trophoblastic Neoplasia | 12/23 | 12/23 | | |
NCT02639650: Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor |
|
|
| Recruiting | 3 | 214 | RoW | Etoposide, VP-16, actinomycin D, ACTD, Sanamycin, methotrexate, MTX, vincristine, VCR, cyclophosphamide, CTX, Paclitaxel, Taxol, Cisplatin, DDP, Carboplatin, CBP | Weiguo Lv, Shandong University, Huazhong University of Science and Technology, First Affiliated Hospital of Zhongshan Medical University | Gestational Trophoblastic Neoplasms | 03/24 | 03/26 | | |
NCT06584032: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer |
|
|
| Recruiting | 3 | 412 | RoW | fruquintinib, HMPL-013, sintilimab, IBI308, paclitaxel, doxorubicin | Hutchmed | Advanced Endometrial Cancer | 01/29 | 06/29 | | |
NCT03885388: Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6 |
|
|
| Recruiting | 2/3 | 300 | RoW | MTX, methotrexate, MTX+ACTD, methotrexate+actinomycin | Women's Hospital School Of Medicine Zhejiang University, Huazhong University of Science and Technology, Qilu Hospital of Shandong University, West China Second University Hospital | Gestational Trophoblastic Tumor, Effects of Chemotherapy, Drug Toxicity | 12/21 | 12/23 | | |
| Completed | 2 | 150 | US, RoW | Paclitaxel, Afuresertib, LAE002 | Laekna Limited | Platinum-resistant Ovarian Cancer | 07/23 | 06/24 | | |
NCT05551507: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer |
|
|
| Recruiting | 1/2 | 150 | RoW | IN10018 in combination with PLD, IN10018 add on to PLD treatment | InxMed (Shanghai) Co., Ltd. | Platinum-resistant Ovarian Cancer | 06/24 | 12/24 | | |
NCT03785574: Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule |
|
|
| Recruiting | N/A | 30 | RoW | Follow up, not chemotherapy immediately, chemotherapy, mtx for low risk | Women's Hospital School Of Medicine Zhejiang University | Hydatidiform Mole, Gestational Trophoblastic Neoplasia | 09/24 | 09/25 | | |
| Not yet recruiting | N/A | 800 | NA | No intervention | Women's Hospital School Of Medicine Zhejiang University | Hydatidiform Mole | 12/26 | 06/27 | | |
